SpectronRx
Kelli Lightfoot has extensive experience in administrative management, serving as Chief Administrative Officer at SpectronRx since 2005 and previously holding the position of Administrative Manager at Zevacor Molecular from January 2013 to April 2015 and at Positron Corp from June 2008 to January 2011. Kelli holds a Bachelor's degree in Business Administration from the University of Evansville, where studies took place from 1998 to 2002, and also participated in a study abroad program at Harlaxton College in 2000.
SpectronRx
1 followers
SpectronRx is a CDMO that is FDA and EMA inspected. We are licensed to handle multiple Therapeutic and Diagnostic isotopes pharmaceutical grade including Pb-212, Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. Spectron provides labeling and contract manufacturing services as it relates to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.